I know the truth doesn't matter, but Vioxx was approved for sale in 1999 by Bill Clinton's FDA even though it was already known to possibly cause cardiovascular problems.
"...Vioxx was approved for sale in 1999 by Bill Clinton's FDA..."
You are right about that. And you are right again: facts don't matter to Liberals.
Exactly.
If ol'Molly want to hang this particular chicken around the appropriate neck, it will be the neck that belongs to her beloved Billy boy.
It only took scrolling 18 posts to get to the info I suspected.
Molly's got mad cow disease.
Molly Ivins always surprises me --- that she can carry out her activities of daily living, much less meet deadlines with her column. The woman hates better than Begala and Carville combined. (Does anyone remember her gloating when her father committed suicide?)
Nevertheless,
The bureaucracy that is the FDA and the NIH (and probably most of the other non-judicial agencies - maybe some of those, although I doubt it, having met so many of them) have been corrupt with those who are looking for the goose that will lay the golden egg in the private sector. It began, and most of the cases I've heard of took place in, the 1990's. Under Clinton
http://www.washingtonpost.com/ac2/wp-dyn/A28128-2004Jul4?language=printer
http://www.latimes.com/la-na-nih7dec07,1,6759172,print.story
After citing multiple cases of NIH corruption in the 1990's, there's this explanation:
""About This Report
In late 1998, the Los Angeles Times began examining payments from drug companies to employees of the National Institutes of Health and the agency's research collaborations with industry. This report is based on records from the federal government and from companies, as well as scores of interviews.
In early 1999, the newspaper first sought income-disclosure reports for all eligible employees of the 27 research institutes and centers of the NIH. The newspaper, as of this month, had filed 36 requests with the NIH for documents under the Freedom of Information Act.
According to NIH staff, the agency has provided documents totaling 13,784 pages, including annual financial-disclosure reports, memos and internal e-mails.
A significant number of NIH employees had by this year stopped filing yearly income reports that are open to public inspection. To assess the relative extent of public financial disclosure at the NIH, The Times in July queried dozens of other federal agencies under the Freedom of Information Act.
Other documentation, describing products and hundreds of research collaborations between the NIH and industry, was retrieved from company and NIH Web sites, from filings with the Securities and Exchange Commission, and from lawsuits filed in federal and state courts. Other related documents were obtained from the Food and Drug Administration under the Freedom of Information Act."""